by Steven Grossman | Mar 7, 2025 | Short Takes and Updates
If you have not signed up to receive the FDA Matters newsletter in your email box, go to the home page to sign up. 1. Taken From This Week’s Headlines Elon Musk learns there is a Budget Control Act protocol, known as recissions, for cutting appropriated funding....
by Steven Grossman | Mar 4, 2025 | Short Takes and Updates
If you have not signed up to receive the FDA Matters newsletter in your email box, go to the home page to sign up. President Trump nominated Johns Hopkin Professor Martin Makary to be the next Commissioner of FDA. His confirmation hearing is Thursday, March 6 at 10...
by Steven Grossman | Feb 27, 2025 | Short Takes and Updates
LIVE EVENT!Come join us tomorrow, (Friday, February 28) at 11 a.m. ET to discuss the need for a regulatory pathway to enable the development of products that extend the span of life free of chronic diseases and...
by Steven Grossman | Feb 25, 2025 | Short Takes and Updates
If you have not signed up to receive the FDA Matters newsletter in your email box, go to the home page to sign up. 1. Never Lose the Whip CountToday (or this week’s) House vote on the reconciliation budget is likely to be one of the most momentous votes in my lifetime...
by Steven Grossman | Feb 23, 2025 | Short Takes and Updates
Information for Reporters[1] Note: Since the original column was published, I have become aware that lay-offs should not be referred to as a reduction-in-force (RIF) because that term triggers certain procedures and protections that employees might not have in the...
by Steven Grossman | Feb 20, 2025 | Short Takes and Updates
If you have not signed up to receive the FDA Matters newsletter in your email box, go to the home page to sign up. 1. FDA At Risk on Four FrontsAll the federal public health programs are under siege. While my focus is on FDA, I want readers to know that NIH and CDC...
